2024
DOI: 10.1186/s12920-023-01775-6
|View full text |Cite
|
Sign up to set email alerts
|

Bioinformatic identification and experiment validation reveal 6 hub genes, promising diagnostic and therapeutic targets for Alzheimer’s disease

Wenyuan Cao,
Zhangge Ji,
Shoulian Zhu
et al.

Abstract: Background Alzheimer’s disease (AD) is a progressive neurodegenerative disease that can cause dementia. We aim to screen out the hub genes involved in AD based on microarray datasets. Methods Gene expression profiles GSE5281 and GSE28146 were retrieved from Gene Expression Omnibus database to acquire differentially expressed genes (DEGs). Gene Ontology and pathway enrichment were conducted using DAVID online tool. The STRING database and Cytoscape … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 41 publications
0
1
0
Order By: Relevance
“…The study successfully establishes a risk score model based on eight epigenetic-related genes, demonstrating its efficacy in predicting CRC patient outcomes in both training and validation sets, and further integrates it with clinical characteristics to enhance prognostic predictions and suggest targeted therapeutic approaches. In 3 , the authors focus on identifying key genes associated with Alzheimer's disease (AD) by analyzing microarray datasets to pinpoint differentially expressed genes (DEGs), employing bioinformatics tools for Gene Ontology and pathway enrichment, and constructing a protein-protein interaction network to isolate hub genes, whose predictive value was further validated through principal component analysis and histological examination of an AD mouse model. In 4 , the authors delve into personalized therapy strategies for liver hepatocellular carcinoma (LIHC) patients by analyzing gene expression profiles and inflammation-related phenotypes to identify characteristic genes and lncRNAs linked to LIHC prognosis, subsequently developing a machine learning-based prognostic model, the Inf-PR model, which demonstrates superior predictive accuracy over traditional prognostic factors and existing models through ten-fold cross-validation.…”
Section: Introductionmentioning
confidence: 99%
“…The study successfully establishes a risk score model based on eight epigenetic-related genes, demonstrating its efficacy in predicting CRC patient outcomes in both training and validation sets, and further integrates it with clinical characteristics to enhance prognostic predictions and suggest targeted therapeutic approaches. In 3 , the authors focus on identifying key genes associated with Alzheimer's disease (AD) by analyzing microarray datasets to pinpoint differentially expressed genes (DEGs), employing bioinformatics tools for Gene Ontology and pathway enrichment, and constructing a protein-protein interaction network to isolate hub genes, whose predictive value was further validated through principal component analysis and histological examination of an AD mouse model. In 4 , the authors delve into personalized therapy strategies for liver hepatocellular carcinoma (LIHC) patients by analyzing gene expression profiles and inflammation-related phenotypes to identify characteristic genes and lncRNAs linked to LIHC prognosis, subsequently developing a machine learning-based prognostic model, the Inf-PR model, which demonstrates superior predictive accuracy over traditional prognostic factors and existing models through ten-fold cross-validation.…”
Section: Introductionmentioning
confidence: 99%